arrow
M

Mohammadreza Mohebbi

Deakin University
H指数:38
被引数:5,307

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data

GLP-1受体激动剂启动与精神分裂症和2型糖尿病成人患者精神科住院和急诊就诊风险:一项基于电子健康记录数据的观察性队列研究

2026-10-140
OAAI
Associations between metabolic dysfunction–associated steatotic liver disease and physical and mental health–related quality of life in older adults

代谢功能障碍相关脂肪性肝病与老年人身心健康相关生活质量的关系

2026-08-080
OAAI
Effect of dispositional optimism and pessimism on the relationship between stressful life events and late-life depression

dispositional optimism 和 pessimism 对压力性生活事件与晚年抑郁之间关系的影响

2026-08-070
OAAI
Diet quality and depressive symptoms in older adults, assessing the effect modification by genetic predisposition and low-grade inflammation: a target trial emulation

老年人群饮食质量与抑郁症状的关系:评估遗传易位和低度炎症的效应修饰作用——一项目标试验模拟研究

2026-07-170
OAAI
Anti-inflammatory diet and mental health outcomes in an aging population: evidence from a preventive population-based target trial emulation

抗炎饮食与老年人群心理健康结局:一项基于预防性人群为基础的目标试验模拟研究的证据

2026-05-190
OAAI
An international, double-blind, randomized, placebo-controlled clinical trial of adjunctive trimetazidine to treat people with bipolar depression (the TIDE trial) protocol

一项关于联合使用曲美他嗪治疗双相抑郁患者的国际、双盲、随机、安慰剂对照临床试验方案(TIDE试验方案)。

2026-04-030
OAAI
The Silexan in the Treatment Of Posttraumatic stress disorder (STOP) trial: protocol for a 12-week randomised controlled trial of adjunctive Silexan for PTSD

Silexan在创伤后应激障碍治疗(STOP)试验:Silexan作为PTSD辅助治疗的12周随机对照试验方案

2026-02-240
OAAI
Associations of the Triglyceride-Glucose Index and Its Obesity-Related Derivative with All-Cause Mortality, Cardiovascular Events, and Long-Term Survival and Functioning in Older Adults

甘油三酯-葡萄糖指数及其肥胖相关衍生指标与全因死亡率、心血管事件以及老年人长期生存和功能状况的关联

2026-02-230
OAAI
Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk. Reply to Choi W [Letter]

正常血糖和糖尿病前期定义对估计从糖尿病前期逆转至正常血糖对2型糖尿病风险益处的影响。回复Choi W [来信]

2025-12-120
PRE